- April 2025, Axonics, Inc. received FDA approval for its third-generation rechargeable SNS system, offering extended battery life (up to 20 years) and enhanced patient comfort with slimmer implants and wireless remote control capabilities.
- March 2025, Medtronic plc launched the InterStim Micro MRI-compatible platform across Europe and Asia-Pacific. It features low-profile leads, rapid recovery protocol, and integration with mobile health apps for real-time monitoring.
- February 2025, Laborie Medical Technologies introduced a new external SNS trial system designed for outpatient settings, enabling clinicians to assess therapy suitability before permanent implantation.
- January 2025, StimGuard LLC announced successful pilot implantation of its wireless, battery-free sacral nerve stimulator—a major innovation aimed at eliminating the need for invasive replacements.
- December 2024, Boston Scientific began clinical trials for a closed-loop SNS system that adjusts stimulation levels automatically based on patient activity and symptom feedback, improving treatment personalization.
